The forecast for hospital discharges due to malignant neoplasm of the prostate in Canada shows a steady decline from 2024 through 2028, starting at 10.04 thousand discharges in 2024 and decreasing to 9.36 thousand in 2028. In 2023, the recorded hospital discharges stood at 10.20 thousand. The year-on-year variation is negative, indicating a consistent reduction in hospital discharges each year. The Compound Annual Growth Rate (CAGR) over the five-year period is negative, emphasizing a slight but steady decrease across these years.
Future trends to watch for include advancements in early detection and treatment methods, which could further reduce hospital discharge rates. Additionally, increasing awareness and preventive measures may play a crucial role in reducing instances of malignant neoplasm of the prostate, impacting future hospital discharge trends positively.
